SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Extreme lateral interbody fusion relieves symptoms of spinal stenosis and low-grade spondylolisthesis by indirect decompression in complex patients.

Pereira, EAC; Farwana, M; Lam, KS (2017) Extreme lateral interbody fusion relieves symptoms of spinal stenosis and low-grade spondylolisthesis by indirect decompression in complex patients. J Clin Neurosci, 35. pp. 56-61. ISSN 1532-2653 https://doi.org/10.1016/j.jocn.2016.09.010
SGUL Authors: Pereira, Erlick Abilio Coelho

[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (95kB)
[img] Microsoft Word (.docx) (Title page) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB)
[img] Microsoft Word (.docx) (Tables) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (18kB)
[img]
Preview
Image (TIFF) (Figure 1) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (169kB) | Preview
[img]
Preview
Image (TIFF) (Figure 2) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (57kB) | Preview
[img]
Preview
Image (TIFF) (Figure 3) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (77kB) | Preview

Abstract

Spinal stenosis and low-grade spondylolisthesis produce symptoms of neural compression that can be treated with extreme lateral lumbar interbody fusion (XLIF) via indirect decompression. This study aimed to investigate whether the restoration of disc dimensions would relieve symptoms of radiculopathy, claudication and back pain. In this retrospective study, patients undergoing XLIF surgery for relief of radicular symptoms or degenerative disc disease were included. Radiologically proven changes were used to assess the modes of degeneration. Objective measures such as the Visual Analogue Scale (VAS) for back and legs and the Oswestry Disability Index (ODI) were used. Complications were collated post-operatively from clinical notes and outpatient appointments. Twenty-three consecutive patients were included, of whom 91% had spinal stenosis. The cohort presented with multiple comorbidities and 35% of the cohort had undergone previous lumbar surgery. There was a 61% improvement of coronal Cobb angle and an 11% correction of the lordosis sustained 1year after surgery. Clinical outcomes at 1year showed 39%, 50% and 60% improvements in the ODI, back and leg VAS scores respectively. 48% of patients had reduced sensation related to lumbosacral plexus manipulation and one retroperitoneal haematoma was conservatively managed. Minimally invasive spinal (MIS) XLIF resulted in effective restoration of disc dimensions via indirect decompression, providing good relief of clinical symptoms evidenced by significant improvement in clinical outcome scores. XLIF corrected scoliosis and improved lumbar lordosis significantly. Several plexopathies did not hinder long-term recovery. XLIF is highly suited to treating complex patients with multiple comorbidities and degenerative disease.

Item Type: Article
Additional Information: © 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: Comorbidities, Extreme lateral interbody fusion (XLIF), Outcomes, Sagittal balance, Spinal stenosis, Spondylolisthesis, Adult, Aged, Cohort Studies, Decompression, Surgical, Female, Humans, Intervertebral Disc Degeneration, Lumbar Vertebrae, Male, Middle Aged, Pain Measurement, Retrospective Studies, Spinal Fusion, Spinal Stenosis, Spondylolisthesis, Treatment Outcome, Comorbidities, Extreme lateral interbody fusion (XLIF), Outcomes, Sagittal balance, Spinal stenosis, Spondylolisthesis, Neurology & Neurosurgery, 1103 Clinical Sciences, 1109 Neurosciences
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: J Clin Neurosci
ISSN: 1532-2653
Language: eng
Dates:
DateEvent
January 2017Published
1 October 2016Published Online
6 September 2016Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
PubMed ID: 27707614
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/108306
Publisher's version: https://doi.org/10.1016/j.jocn.2016.09.010

Actions (login required)

Edit Item Edit Item